Immune checkpoint inhibitor-related thrombocytopenia: Incidence, risk factors, and effect on overall survival.
2021
e14549Background: Immune checkpoint inhibitors (ICI) are a standard of care therapy for patients with many different cancers. ICI are generally well tolerated but are associated with unique immune-...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI